Engineered sialylated IgG1 Fc as a dose-sparing alternative to IVIG

Nature Reviews Rheumatology 2026

View at publisher

Authors: Sruthi Vijaya Retnakumar, Jagadeesh Bayry

DOI: 10.1038/s41584-025-01347-1

Cited by: 0

References: 10

Fields of Study & Subjects

Monoclonal and Polyclonal Antibodies Research Platelet Disorders and Treatments Glycosylation and Glycoproteins Research

References 10